The expansion ability but not the quality of HIV-specific CD8 + T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors

Immunology

Volumn 134, Issue 3, 2011, Pages 305-313

  López, Mariola ^a   Peris, Alejandra ^a   Soriano, Vincent ^a   Lozano, Sara ^a   Vicario, José Luis ^b   Rallón, Norma I ^a   Restrepo, Clara ^a   Benito, José M ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

CD8 + T cell response; Cytokines; Expansion ability; HIV; HLA class I; LTNP

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; GAG PROTEIN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA B27 ANTIGEN; HLA B58 ANTIGEN; INTERLEUKIN 2; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NEF PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CYTOKINE RELEASE; DISEASE COURSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE CULTURE; MALE; PRIORITY JOURNAL; PROTECTION; T LYMPHOCYTE SUBPOPULATION; VIRUS REPLICATION;

ADULT; ALLELES; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CCL4; FEMALE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENE FREQUENCY; HIV; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HLA-B ANTIGENS; HLA-B27 ANTIGEN; HUMANS; INTERLEUKIN-2; MALE; MIDDLE AGED; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 80053641103     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2011.03490.x     Document Type: Article

References (25)

1. + cytotoxic T-lymphocyte activity associated with control of viremia in primary HIV type 1 infection. J Virol 1994; 68:6103-10.
2. Koup R, Safrit J, Cao Y, Andrews C, McLeod G, Borkowsky W, Farthing C, Ho D. Temporal association of cellular immune responses with the initial control of viremia in primary HIV type 1 syndrome. J Virol 1994; 68:4650-5.
3. + T-cells. Blood 2006; 107:4781-9.
4. + T cell proliferation is coupled to perforin expression and is maintained in non-progressors. Nat Immunol 2002; 3:1061-8.
5. + responses between long-term nonprogressors and typical progressors. AIDS Res Hum Retroviruses 2008; 24:1185-95.
6. Horton H, Frank I, Baydo R et al. Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection. J Immunol 2006; 177:7406-15.
7. + T cells. Eur J Immunol 2008; 38:1548-58.
8. Migueles SA, Sabbaghian MS, Shupert WL et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA 2000; 97:2709-14.
9. Philip J, Goulder R, Watkins DI. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 2008; 8:619-30.
10. Emu B, Sinclair E, Hatano H, Ferre A, Shacklett B, Martin JN, McCune JM, Deeks SG. HLA class I-restricted t-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control. J Virol 2008; 82:5398-407.
11. Rodés B, Toro C, Paxinos E et al. Differences in disease progression in a cohort of long-term non-progressors after more than 16years of HIV-1 infection. AIDS 2004; 18:1-8.
12. Kaslow RA, Carrington M, Apple R et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996; 2:405-11.
13. Carrington M, O'Brien SJ. The influence of HLA genotype on AIDS. Annu Rev Med 2003; 54:535-51.
14. Limou S, Le Clerc S, Coulonges CD et al. Genomewide Association Study of an AIDS nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J Infect Dis 2009; 199:419-26.
15. + T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 2007; 13:46-53.
16. Harari A, Cellerai C, Enders FB et al. Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype. Proc Natl Acad Sci USA 2007; 104:16233-8.
17. Arrizabalaga J, Rodriguez-Alcántara F, Castañer JL et al. Prevalence of HLA-B*5701 in HIV-infected patients in Spain (results of the EPI Study). HIV Clin Trials 2009; 10:48-51.
18. Hersperger AR, Pereyra F, Nason M et al. Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control. PLoS Pathog 2010; 6:e1000917.
19. Betts MR, Krowka JF, Kepler TB et al. HIV type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors. AIDS Res Hum Retrovir 1999; 15:1219-28.
20. + T-cell responses: relationship to viral load in untreated HIV infection. J Virol 2001; 75:11983-91.
21. + T-cells in individuals receiving highly active antiretroviral therapy (HAART). J Immunol 1999; 162:1780-8.
22. + T-Cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy. J Virol 2009; 83:11876-89.
23. Kan-Mitchell J, Bajcz M, Schaubert KL et al. Degeneracy and repertoire of the human HIV-1 Gag p1777-85 CTL response. J Immunol 2006; 176:6690-701.
24. Kalams SA, Buchbinder SP, Rosenberg ES et al. Association between virus-specific cytotoxic T-lymphocyte and helper responses in HIV type 1 infection. J Virol 1999; 73:6715-20.
25. Loffredo JT, Sidney J, Bean AT et al. Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity. J Immunol 2009; 182:7763-75.